| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | OSI-930 | CTRPv2 | pan-cancer | AAC | 0.16 | 4e-05 |
| mRNA | NSC632839 | CTRPv2 | pan-cancer | AAC | 0.15 | 4e-05 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | 0.17 | 5e-05 |
| mRNA | BMS-345541 | GDSC1000 | pan-cancer | AAC | 0.13 | 5e-05 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.13 | 6e-05 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | 0.13 | 7e-05 |
| mRNA | alisertib:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.15 | 7e-05 |
| mRNA | manumycin A | CTRPv2 | pan-cancer | AAC | 0.14 | 8e-05 |
| mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | 0.15 | 8e-05 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | 0.14 | 9e-05 |